FDA Recalls Deodorant Over Manufacturing Issues Affecting 67,000+ Power Stick Cases

Generated by AI AgentWord on the Street
Monday, Jul 21, 2025 6:39 pm ET1min read
Aime RobotAime Summary

- FDA recalls 67,000+ Power Stick deodorant cases due to CGMP manufacturing deviations at A.P. Deauville.

- Three 1.8-oz variants distributed nationwide via retailers like Dollar Tree and Amazon are affected.

- Consumers advised to stop use and return products despite no reported adverse effects.

- Recall underscores industry challenges in maintaining FDA safety standards for consumer products.

The U.S. Food and Drug Administration has initiated a recall affecting more than 67,000 cases of Power Stick deodorants due to concerns regarding manufacturing practices. This action, initiated on July 10, targets specific Power Stick deodorant varieties that are distributed across the nation and available at retailers such as

and . The products affected by this recall include the Power Stick for Her Roll-On Antiperspirant Deodorant Powder Fresh, the Power Stick Invisible Protection Roll-On Antiperspirant Deodorant Spring Fresh, and the Power Stick Original Nourishing Invisible Protection Roll-On Antiperspirant Deodorant.

Manufactured by A.P. Deauville, the recall pertains specifically to deviations from the FDA's Current Good Manufacturing Practices (CGMP). These standards require that products are manufactured with the appropriate methods, facilities, and controls to ensure safety, quality, and labeled potency. The FDA has not detailed the specific shortcomings but indicates the recall is a precaution due to these CGMP deviations.

All the recalled varieties come in a 1.8-ounce package size and include specific lot numbers. For instance, the Power Stick for Her deodorant has been produced in 21,265 cases, the Invisible Protection Roll-On Spring Fresh has 22,482, and the Original Nourishing Invisible Protection Roll-On tallies at 23,467 cases. These products, produced in A.P. Deauville’s FDA-regulated Pennsylvania factory, highlight the necessity for stringent adherence to established production norms to avoid recall situations that pertain to consumer safety.

Reports confirm the products were distributed nationwide, emphasizing the broad impact of the recall due to the widespread availability of these items. Although no adverse effects from usage have been reported, consumers who have purchased these specific deodorant products are advised to immediately discontinue their use. The FDA recommends that consumers dispose of them or return them to the point of purchase.

This recall highlights ongoing challenges within the personal care product industry to consistently meet regulatory standards designed to safeguard public health. Consumers querying about the recall for further information are encouraged to consult the FDA's official website or contact the retailer involved in their purchase. The regulatory body remains firm in its stance on maintaining rigorous safety standards for all manufacturing processes to ensure products meet their intended design, safety, and quality comprises rigorously.

As this recall progresses, manufacturers like A.P. Deauville are reminded of the critical importance of compliance with FDA regulations to prevent both safety risks to consumers and potential disruptions in market operations. Meanwhile, industry stakeholders and consumers remain vigilant as they navigate these regulatory landscapes, keeping a watchful eye on developments pertaining to product safety and manufacturing integrity.

Comments



Add a public comment...
No comments

No comments yet